-
Georgia State Contract, Services for Sickle Cell Anemia Patients, Newborn Screening confirmation program
2006 - Present
Role: Program Coordinator
-
Primary Coordinator: TCD With Transfusions Changing to Hydroxyurea (TWiTCH)
2011 - 2016
-
Lab Coordinator: CLBH589BUS43T: Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease
2009 - 2016
-
Lab Coordinator: CC-4047-SCD-001 Trial, A Prospective, Multi-center, Open-Label, Dose-Escalation Study to determine the maximum tolerated dose, safety and effect of induction of fetal hemoglobin of CC-4047 in subjects with Sickle Cell Disease, Celgene Corporation
2008 - 2015
-
Lab Coordinator: Mu Opioid Polymorphisms as Genetic Modifiers of Pain and Opioid Use In SCD
2009 - 2014